Clinical Trials Browser

Phase 2 × Uterine Cervical Neoplasms × Etoposide × Clear all

NCT05910177 2024-03-06

Neoadjuvant Treatment of Neuroendocrine Cervix Carcinomar With Camrelizumab Combined With Etoposide and Cisplatin

Phase 2 Recruiting

Carcinoma, Uterine Cervical Neoplasms

NCT00002478 2013-06-10

Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer

Phase 2 Terminated

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Ovarian Neoplasms